Why I'm Introducing Hyperdilute Radiesse to My Clinic
A version of the same consultation had been happening in my clinic room for about a year.
A woman in her late forties or fifties sits down and tells me she is happy enough with her face. She has looked after her skin. She uses good products. She has had treatments she was pleased with. Then she pulls down her collar slightly and says "but look at my neck". Or she puts her hands on the desk and says her face looks fine but her hands have given the game away. Or she has lost two stone, which she is delighted about, and the skin across her stomach now looks thin and papery in a way it did not before.
And for a long time my honest answer was that I could not do a great deal about it.
I could offer skincare, which helps but works at the surface. I could offer medical microneedling, which is excellent for texture but is not really addressing structural support. I could offer a hydrating injectable, which does something worthwhile but not the thing these patients were actually describing. What I could not offer was a treatment that credibly targeted the loss of collagen and structural support in the deeper tissue of the neck and body, which is what had genuinely changed.
So I have spent a considerable amount of time reading about hyperdilute Radiesse before deciding to offer it. This post is about why I said no for a long time, what changed, and where I still think the evidence is thinner than the marketing suggests.
In this article
- Why I was slow to offer body treatments
- The three questions I needed answered
- What the evidence looks like, area by area
- How it fits alongside the treatments I already offer
- What I am not claiming
- The off-label conversation
- Who I will treat, and who I will turn away
- What I will be watching over the next twelve months
- References
Why I Was Slow to Offer Body Treatments
Aesthetic medicine has a body problem. The face has decades of published data behind it. The body, historically, has had a great deal of enthusiasm and comparatively little evidence.
Every year there is a device or an injectable promising to tighten the abdomen, smooth the arms or lift the buttocks without surgery. Some of them work modestly. Some of them work for a very specific patient and are then sold to everybody. And a few of them do very little at all beyond producing swelling that patients understandably mistake for a result for the first fortnight.
My default position on any new treatment is no, until I can explain to a patient exactly what it is doing and why I believe it. That is not caution for its own sake. It is because I sit in an NHS consulting room several days a week where the standard of proof is higher, and I do not think patients paying privately deserve a lower one.
The question I ask about a new treatment is not "does it have a good story". It is "if a colleague asked me to justify offering this, could I".
For a long time, for body skin, the answer was no.
The Three Questions I Needed Answered
1. Does diluting a biostimulator weaken it?
This was my first and most obvious objection. If you take a product and add several times its volume in saline, the intuitive assumption is that you have made it weaker. If that were true, hyperdilution would simply be a way of charging for a smaller amount of active product.
It turns out the intuition is wrong, and understanding why is what changed my thinking.
Radiesse works because direct contact between fibroblasts and the calcium hydroxylapatite microspheres is what drives collagen formation. The gel carrier is not the active ingredient. The microspheres are. When you dilute the product, you are not reducing the number of microspheres in the syringe. You are spreading the same microspheres across a much wider area of tissue and putting a far greater number of fibroblasts into contact with them.
For facial contouring with standard Radiesse you want the product concentrated, because you want lift and projection. For skin quality across a broad, thin area like the neck or the chest, concentration is precisely what you do not want. You want contact area. Published work has directly compared the dermal stimulation potential of diluted against concentrated formulations, and a 2025 review of the mechanism in the Aesthetic Surgery Journal notes that dilution maintains and in some protocols optimises neocollagenesis rather than diminishing it.
Once I understood that, hyperdilution stopped looking like a way of stretching a syringe and started looking like a deliberate change of purpose.
2. What is it actually doing in the tissue?
I am not satisfied by "it stimulates collagen". Almost everything in aesthetics claims to stimulate collagen. I wanted to know the sequence.
The mechanism, as currently understood, is more interesting than I expected:
That last line is the part that matters clinically, and it is the part I want patients to understand.
You are not paying for a product to sit in your neck. You are paying for a controlled biological prompt, and then the product leaves. What you keep is what your own tissue made.
It also explains the timeline honestly. If type I collagen does not begin to predominate until around three months, then anybody promising you a tightened neck in a fortnight is describing swelling, not collagen.
3. Is there real evidence for the body, or only for the face?
This was the question that took longest, and the answer is genuinely mixed. Which is why I am setting it out honestly rather than presenting all five body areas as though they carry equal weight.
What the Evidence Looks Like, Area by Area
Two observations about that table.
First, the neck evidence is the one that persuaded me most, despite not being the strongest study design. The reason is that it measured dermal thickness on ultrasound rather than relying only on someone looking at a photograph and forming an opinion. A 15% increase in dermal thickness is an objective finding. It is much harder to argue away than a satisfaction score, and it corresponds directly to the mechanism described above.
Second, the knee and abdomen evidence is genuinely thin, and I am not going to pretend otherwise. I will offer treatment in those areas, because a small pilot study plus a coherent mechanism plus a well-tolerated product is a reasonable basis for carefully selected use. But a patient asking me about knees deserves to know that the published evidence is one small study, and I will tell them so.
There are also published consensus recommendations from international expert groups on dilution ratios and technique for face and body use, which is a useful sign that this is established practice with an agreed methodology rather than something individual clinics are improvising.
How It Fits Alongside the Treatments I Already Offer
The obvious objection to a clinic adding a treatment is that clinics like adding treatments. So the fair question is whether this does something the others do not.
Read down that table and the gap is fairly clear. Nothing I was already offering was targeting deep structural support across a broad area of body skin. The nearest option was Sculptra, which is an excellent product but which I use differently and predominantly on the face.
That is the test I apply before adding anything: does it fill a genuine gap, or does it just give me another thing to sell to the same patient? If a new treatment overlaps almost entirely with something I already have, I do not need it, however good the rep's presentation was.
What I Am Not Claiming
I would rather write this section than have a patient discover it after paying.
This is not a neck lift. It improves skin quality and mild laxity. If you have significant hanging skin, no injectable will address it and I will tell you that at consultation rather than take your money and hope.
This is not a tummy tuck. If you have substantial loose abdominal skin after pregnancy or major weight loss, or significant muscle separation, this is the wrong treatment and you should be seeing a surgeon.
This is not immediate. Anything you see in the first two weeks is swelling. The real change happens over months, in the sequence set out above.
This is not permanent. The product biodegrades completely. The collagen response outlasts it, but it is not forever, and maintenance at around a year is realistic.
And it is not for everybody. Some patients will get a modest improvement that does not justify the cost, and part of my job is to identify those people beforehand and say so.
The Off-Label Conversation
I want to be straightforward about something that many clinics leave out of their marketing.
Radiesse is licensed in the UK for specific indications. Its use in hyperdiluted form, and its use across several of the body areas I have described, falls outside those standard licensed indications.
This is common, well-established and entirely lawful practice in aesthetic medicine, it is supported by published evidence and international consensus recommendations, and doctors do it thoughtfully across many fields of medicine. But it is not something a patient should find out afterwards. Where it applies to you, I will explain it clearly as part of your consultation and it will form part of your written consent. If you would prefer to stay strictly within licence, I will tell you what your alternatives are.
A patient who has been told about off-label use and consented to it is in a completely different position from one who was simply never told. The treatment is the same. The relationship is not.
Who I Will Treat, and Who I Will Turn Away
The right-hand column is the more important one. The single biggest determinant of whether someone is happy with this treatment is whether they were the right patient for it in the first place, and that decision happens at consultation, not at injection.
What I Will Be Watching Over the Next Twelve Months
Introducing a treatment is not the end of the assessment. It is the beginning of it. These are the things I will be tracking in my own patients:
Whether the neck results hold up in practice. The published dermal thickness data is encouraging, but published studies are conducted under ideal conditions with selected patients. I want to see it in my own clinic, photographed consistently, at three and six months.
Whether two sessions is genuinely enough. The protocol is two treatments six to eight weeks apart. If I find that a meaningful proportion of patients need a third, I would rather know that and say so upfront than let people discover it after they have budgeted for two.
How the knees and abdomen actually perform. This is where the evidence is thinnest and where I have the least certainty. If the results in my own patients do not justify the cost, I will stop offering it in those areas and I will say why.
Whether patients understand the timeline. The biggest risk with any biostimulator is a patient who expected a filler. If people are coming to their two-week review disappointed, that is a failure of my consultation rather than a failure of the product.
The Honest Summary
I am introducing hyperdilute Radiesse because it addresses a problem I was regularly being asked about and could not previously solve well, because the mechanism is coherent and specific rather than vague, and because for the neck, décolletage and hands in particular there is published clinical evidence of a quality I am comfortable standing behind.
I am introducing it with clear limits. It is not surgery. It is not immediate. It is not permanent. The evidence for the knees and abdomen is thin and I will say so every time. And it is used outside its standard licence in most of these areas, which every patient will be told before they consent.
If you have looked after your skin for years and your neck, chest or hands have changed anyway, this is not a failure on your part. It is a change in the structure underneath, and that is a different problem needing a different solution.
You can read the full detail on the hyperdilute Radiesse treatment page, including pricing, treatment areas and what to expect afterwards.
If that sounds like you, you are welcome to book a consultation and we will work out together whether this is the right treatment, or whether something else, or nothing at all, would serve you better.
References
- van Loghem J. Calcium Hydroxylapatite in Regenerative Aesthetics: Mechanistic Insights and Mode of Action. Aesthetic Surgery Journal. 2025;45(4):393 to 403.
- The Comparative Dermal Stimulation Potential of Constant-Volume and Constant-Amount Diluted Calcium Hydroxylapatite Injections Versus the Concentrated Form. Dermatologic Surgery. 2023.
- Goldman MP, et al. Calcium Hydroxylapatite Dermal Filler for Treatment of Dorsal Hand Volume Loss: Results From a 12-Month, Multicenter, Randomized, Blinded Trial. Dermatologic Surgery. 2018.
- Pavicic T, et al. A Prospective, Multicenter, Evaluator-Blinded, Randomized Study of Diluted Calcium Hydroxylapatite to Treat Décolleté Wrinkles. Journal of Drugs in Dermatology. 2024.
- Fabi S, Moradi A, Hill D, et al. Diluted Calcium Hydroxylapatite Carboxymethylcellulose (Radiesse) for Décolleté Wrinkles: Safety and Effectiveness in Adult Females. Aesthetic Surgery Journal. 2026.
- Muniz M, et al. Efficacy and Tolerability of Hyperdiluted Calcium Hydroxylapatite (Radiesse) for Neck Rejuvenation: Clinical and Ultrasonographic Assessment. Clinical, Cosmetic and Investigational Dermatology. 2023.
- Guida S, et al. Hyperdiluted calcium hydroxylapatite for the treatment of skin laxity of the neck. Dermatologic Therapy. 2021.
- Guida S, et al. Hyperdiluted calcium hydroxylapatite for skin laxity and cellulite of the skin above the knee: A pilot study. Dermatologic Therapy. 2020.
- Lapatina NG, Pavlenko T. Diluted Calcium Hydroxylapatite for Skin Tightening of the Upper Arms and Abdomen. Journal of Drugs in Dermatology. 2017.
- de Almeida AT, et al. Consensus Recommendations for the Use of Hyperdiluted Calcium Hydroxyapatite (Radiesse) as a Face and Body Biostimulatory Agent. Plastic and Reconstructive Surgery Global Open. 2019.
- Casabona G, et al. Global Consensus Guidelines for the Injection of Diluted and Hyperdiluted Calcium Hydroxylapatite for Skin Tightening. Dermatologic Surgery. 2019.
Next steps
Learn more about Dr Caroline Warden Clinic
Learn more about other treatments offered
Written by Dr Caroline Warden, MBChB, NHS GP and aesthetic doctor at Dr Caroline Warden Skin & Aesthetic Clinic, Hale, Altrincham. GMC number 6157708. Published August 2026.
